| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |